ArticleJournal of fluorescence2026
High-Photostability Perylene-Derived Probe Enables Accurate Dual-Modality Imaging of Mitochondrial Membrane Potential.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Mitochondrial membrane potential (MMP) is a key indicator of mitochondrial function and cellular health. Fluorescence intensity-based methods are widely used for MMP monitoring, where probe photostability is critical for accurate quantification. To improve imaging reliability, we developed a photostable mitochondrial-targeted probe, PDI-TPP, by linking perylene diimide (PDI) with triphenylphosphonium (TPP). To the best of our knowledge, this is the first report of PDI being rationally designed and synthesized as a FRET donor for MMP sensing. Acting as a FRET donor, PDI-TPP pairs with SiR-BA, which is synthesized by conjugating silicon-rhodamine with butyric acid, to achieve dual-modality imaging through both fluorescence intensity ratio and lifetime. Compared to our previous donor OR-C8, PDI-TPP shows significantly enhanced photostability, reducing photobleaching artifacts and enabling dynamic visualization of MMP changes. This work provides a more accurate tool for mitochondrial imaging and functional studies.
Indexed as
Identifiers
41483265What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.